Scarica l'app Stockscreener
3.316
1.34%
-0.044
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Anavex Life Sciences Corp Borsa (AVXL) Ultime notizie
Anavex appoints interim CEO following leadership change By Investing.com - Investing.com Canada
CEO ousted as Anavex (NASDAQ: AVXL) board installs interim chief and eyes 10-Q delay - Stock Titan
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating - Investing.com
H.C. Wainwright initiates Anavex Life Sciences stock with buy rating By Investing.com - Investing.com Canada
MSN Money - MSN
Director Axel Paeger files initial Form 3 for Anavex (AVXL) - Stock Titan
AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200 Day Moving AverageTime to Sell? - MarketBeat
AVXL stock soars after Anavex’s new data suggests its Alzheimer’s drug may slow brain shrinkage - MSN
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's - MSN
Anavex stock slides after hours on EMA panel’s negative Alzheimer’s drug opinion — retail traders talk buyout potential - MSN
What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks - Yahoo Finance
Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN
Anavex Life Sciences (NASDAQ:AVXL) Share Price Passes Below 200-Day Moving AverageTime to Sell? - MarketBeat
Anavex (AVXL) Stock: Buy or Sell? (+7.06%) 2026-04-18High Interest Stocks - Xã Vĩnh Công
AVXL | Anavex Life Sciences Insider Trading - Quiver Quantitative
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology between Autism and Alzheimer's disease - marketscreener.com
Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference - MarketBeat
Anavex Life Sciences Advances Blarcamesine Research, Highlighting Shared Autophagy Mechanisms in Autism and Alzheimer’s Disease - Quiver Quantitative
Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease - marketscreener.com
Autistic adults had up to 8x dementia rates in research Anavex cites - Stock Titan
Anavex links autism and Alzheimer’s via autophagy dysfunction - Investing.com
Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your RightsAVXL - ACCESS Newswire
Aug Rallies: Does Anavex Life Sciences Corp have strong fundamentalsMarket Activity Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Shareholders to Connect - ACCESS Newswire
AVXL Technical Analysis | Trend, Signals & Chart Patterns | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
AVXL Q1 2026 Earnings: Anavex Life Sciences beats EPS ests, no revenueConsensus Forecast - UBND thành phố Hải Phòng
Aug Retail: Is Anavex Life Sciences Corp stock trending bullish2026 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Anavex Life Sciences Corp. to Present at 25th Annual Needham Virtual Healthcare Conference - Quiver Quantitative
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Anavex Life Sciences Corp. (AVXL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:AVXL | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Investors to Connect - ACCESS Newswire
Anavex Life Sciences Corp. (AVXL) stock price, news, quote and history - Yahoo Finance UK
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Anavex Life Sciences Corp. (AVXL) And Encourages Investors to Connect | NDAQ:AVXL | Press Release - stockhouse.com
3 Promising Penny Stocks With At Least $200M Market Cap - Sahm
Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 635% Upside in Biotechnology - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages Anavex Life Sciences Corp. (AVXL) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Anavex Life Sciences Corp (12X1.HM) Recent Insider Transactions - Yahoo! Finance Canada
AVXL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Anavex Life Sciences' (AVXL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
Anavex Life Sciences Provides Comprehensive Regulatory Update - The Manila Times
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):